HKSE:01349 (China)
Â
Class H
HK$
2.27
(-0.44%)
Jan 15
New Key Statistics Module, Z-Score and F-Score
HKSE:01349 Key Ratios
| Market Cap HK$ M | 6,316.52 |
| Enterprise Value HK$ M | 5,060.09 |
| P/E(ttm) | 21.52 |
| PE Ratio without NRI | 21.94 |
| Forward PE Ratio | -- |
| Price/Book | 0.93 |
| Price/Sales | 3.20 |
| Price/Free Cash Flow | 141.25 |
| Price/Owner Earnings | 56.50 |
| Payout Ratio % | 0.95 |
| Revenue (TTM) HK$ M | 751.00 |
| EPS (TTM) HK$ | 0.10 |
| Beneish M-Score | -2.29 |
| 10-y EBITDA Growth Rate % | 2.40 |
| 5-y EBITDA Growth Rate % | -5.30 |
| y-y EBITDA Growth Rate % | 134.40 |
| EV-to-EBIT | 46.48 |
| EV-to-EBITDA | 29.01 |
| PEG | -- |
| Shares Outstanding M | 1,043.00 |
| Net Margin (%) | 15.16 |
| Operating Margin % | 13.65 |
| Pre-tax Margin (%) | 14.04 |
| Quick Ratio | 3.77 |
| Current Ratio | 3.88 |
| ROA % (ttm) | 3.62 |
| ROE % (ttm) | 4.46 |
| ROIC % (ttm) | 8.62 |
| Dividend Yield % | 4.27 |
| Altman Z-Score | 8.55 |
HKSE:01349 Number of Guru Trades
HKSE:01349 Volume of Guru Trades
Gurus Latest Trades with HKSE:01349
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:01349 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Insider Transactions
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers